Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Robertson

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Virulence|June 13, 2020
A novel biosafety level 2 compliant tuberculosis infection model using a Δ<i>leuD</i>Δ<i>panCD</i> double auxotroph of <i>Mycobacterium tuberculosis</i> H37Rv and <i>Galleria mellonella</i>Masanori Asai, Yanwen Li, John Spiropoulos, et al.
Journal of Visualized Experiments : Jove|July 16, 2019
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis ComplexMasanori Asai, Yanwen Li, Jasmeet Singh Khara, et al.
Comparative Immunology, Microbiology and Infectious Diseases|February 7, 2012
The influence of cattle breed on susceptibility to bovine tuberculosis in EthiopiaMartin Vordermeier, Gobena Ameni, Stefan Berg, et al.
Journal of Clinical Anesthesia|December 8, 2007
Metoclopramide does not influence the frequency of propofol-induced spontaneous movementsFima Lenkovsky, Brian D Robertson, Chandramouli Iyer, et al.
Nature Communications|September 9, 2022
Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteriaYuzhe Weng, Dawn Shepherd, Yi Liu, et al.
Microbiology Spectrum|July 4, 2026
Metabolomics profiling reveals changes in peptidoglycan and redox metabolism between ancient and modern <i>Mycobacterium tuberculosis</i>Ashleigh Cheyne, Elisabeth V Oskoui, Agnieszka Broda, et al.
The Journal of Antimicrobial Chemotherapy|May 2, 2013
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferaseNuria Andreu, Andrea Zelmer, Samantha L Sampson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 25, 2021
Improving sleep medicine education among health professions traineesStephanie R Wappel, Steven M Scharf, Larry Cohen, et al.
Emerging Topics in Life Sciences|December 14, 2020
Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologiesKhaled H Alzahabi, Omar Usmani, Theoni K Georgiou, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2010
Targeting the chromosome partitioning protein ParA in tuberculosis drug discoveryShahista Nisa, Marian C J Blokpoel, Brian D Robertson, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Virulence|June 13, 2020
A novel biosafety level 2 compliant tuberculosis infection model using a Δ<i>leuD</i>Δ<i>panCD</i> double auxotroph of <i>Mycobacterium tuberculosis</i> H37Rv and <i>Galleria mellonella</i>Masanori Asai, Yanwen Li, John Spiropoulos, et al.
Journal of Visualized Experiments : Jove|July 16, 2019
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis ComplexMasanori Asai, Yanwen Li, Jasmeet Singh Khara, et al.
Comparative Immunology, Microbiology and Infectious Diseases|February 7, 2012
The influence of cattle breed on susceptibility to bovine tuberculosis in EthiopiaMartin Vordermeier, Gobena Ameni, Stefan Berg, et al.
Journal of Clinical Anesthesia|December 8, 2007
Metoclopramide does not influence the frequency of propofol-induced spontaneous movementsFima Lenkovsky, Brian D Robertson, Chandramouli Iyer, et al.
Nature Communications|September 9, 2022
Inhibition of the Niemann-Pick C1 protein is a conserved feature of multiple strains of pathogenic mycobacteriaYuzhe Weng, Dawn Shepherd, Yi Liu, et al.
Microbiology Spectrum|July 4, 2026
Metabolomics profiling reveals changes in peptidoglycan and redox metabolism between ancient and modern <i>Mycobacterium tuberculosis</i>Ashleigh Cheyne, Elisabeth V Oskoui, Agnieszka Broda, et al.
The Journal of Antimicrobial Chemotherapy|May 2, 2013
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferaseNuria Andreu, Andrea Zelmer, Samantha L Sampson, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 25, 2021
Improving sleep medicine education among health professions traineesStephanie R Wappel, Steven M Scharf, Larry Cohen, et al.
Emerging Topics in Life Sciences|December 14, 2020
Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologiesKhaled H Alzahabi, Omar Usmani, Theoni K Georgiou, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2010
Targeting the chromosome partitioning protein ParA in tuberculosis drug discoveryShahista Nisa, Marian C J Blokpoel, Brian D Robertson, et al.
Pageof 10